Innovation Pharmaceuticals Inc (IPIX)

[frrol]

Folks should also keep in mind that there is nothing magical about "Q2'18". That was simply the broad target (ie estimate) given by the company, which was apparently having some issue with the CRO, and apparently now resolved. According to Leo we should get results soon, first hearing about database lock, hopefully accompanied with a time estimate of unblinding and top result release.

Good results would be something comparable to Otezla: at least one arm around 35% PASI-75 at 16 weeks. If 40-50% range, would be excellent. Above 50% would be shoot out the lights.

We need P strong results just to get our capital costs down, a B deal is a strong possibility but timing unknowable to us and the market.